中山招聘

In scope of quality assurance, responsible for products quality related monitoring, including BPR review, materials check, deviation and non-conformance handling follow up, collect and confirm the equipment maintain, complete instance of process and materials changes, and assist the GMP training for workshop staffs. Effectively perform quality control and assurance role in material flow, manufacturing activities, etc process and product relevant activities.
在质量保证范围内，负责与生产相关的各项质量保证工作。包括批记录的审查，物料检查，生产过程中偏差/不符合情况的整改跟进，收集和确认设备维修、工艺、物料等变更完成情况，协助完成对车间员工实施GMP培训工作。有效的对物流、生产活动进行质量控制和质量保证。



(1) Responsible for in process control of manufacturing activities and packaging activities. Ensure manufacturing process always follows up Chinese GMP and group’s requirement.
负责生产现场、包装现场的过程控制。确保生产活动符合中国GMP以及诺华的要求

(2) Responsible for monitoring of environment conditions in the clean areas, responsible for purified water system monitoring program.
负责洁净区的环境监测，负责生产用纯化水系统的质量监控。

(3) Responsible for handle all kinds of deviations related to material control and manufacturing process, work with relevant dept to define CAPA and monitoring implementation of CAPAs.
负责物料和生产工艺相关的偏差处理，与各部门沟通确定相关的纠正预防措施并实施。

(4) Re Responisble for validation support in manufacturing dept.
支持生产部的验证实施。

(5) Responsible for BPR review, responsible for production and material related documents review.
负责批记录的审核，负责生产和物料相关的文件审核。

(6) Responsible for change control input from QA perspective
负责从QA方面对变更进行评估。

(7) Support prodution dept to resolving product issues.
协助生产部门进行产品问题的解决。

(8) Support QP to release products
协助质量受权人进行产品方行。

(9) Responsible for following up the relevant CAPAs.
负责审计中相关的整改内容的跟进。

(10) Be accountable for SOP, GMP, QM ,CHSE compliance and China laws and regulation.
必须有责任地符合SOP, GMP, 质量手册,集团安全健康环境和中国法律法规的要求.

(11) As a member of Quality Council and Complaint Handling Council, participate in handling quality and complaint related issue.
作为中山工厂质量委员会及投诉处理委员会成员，参与协调和处理与质量和投诉相关事务.

山德士是瑞士诺华集团的子公司，诺华集团是世界第三大制药公司、世界500强企业，是全球唯一在专利药、非专利药、疫苗和非处方药业务上都拥有领导地位的制药公司。诺华集团成立于1996年，由瑞士两家具有百年历史的世界著名制药公司汽巴-嘉基与山德士合并而成。山德士主要从事非专利药品的研发、生产和销售，业务涵盖原料药、制剂和生物制品，拥有950多个化合物和5000多种制剂，是全球第二大非专利药公司。山德士（中国）2007年1月正式开展中国业务，于当年12月20日向德国格兰泰公司收购了位于中山市火炬区健康基地的中山格兰泰制药，并在中山成立了山德士(中国)制药有限公司，注册资金2200万美元，投资总额达3500万美元.